Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SpringWorks Therapeutics, Inc. | Chief Operating Officer | Common Stock | 230K | $9.66M | $42.08 | Sep 3, 2024 | Direct |
SpringWorks Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 120K | Jan 4, 2024 | Direct | ||
Edgewise Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20.6K | Jun 10, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SWTX | SpringWorks Therapeutics, Inc. | Sep 3, 2024 | 3 | -$813K | 4 | Sep 4, 2024 | Chief Operating Officer |
EWTX | Edgewise Therapeutics, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
SWTX | SpringWorks Therapeutics, Inc. | Jun 3, 2024 | 4 | -$801K | 4 | Jun 5, 2024 | Chief Operating Officer |
SWTX | SpringWorks Therapeutics, Inc. | Jan 4, 2024 | 4 | -$397K | 4 | Jan 8, 2024 | Chief Operating Officer |
EWTX | Edgewise Therapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
SWTX | SpringWorks Therapeutics, Inc. | Jan 5, 2023 | 4 | -$91.5K | 4 | Jan 9, 2023 | Chief Operating Officer |
EWTX | Edgewise Therapeutics, Inc. | Jun 24, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
SWTX | SpringWorks Therapeutics, Inc. | Jan 7, 2022 | 1 | -$39.2K | 4 | Jan 10, 2023 | Chief Operating Officer |
SWTX | SpringWorks Therapeutics, Inc. | Jan 7, 2022 | 1 | -$104K | 4/A | Jan 14, 2022 | Chief Operating Officer |
SWTX | SpringWorks Therapeutics, Inc. | Jan 6, 2022 | 2 | $0 | 4 | Jan 10, 2022 | Chief Operating Officer |
SWTX | SpringWorks Therapeutics, Inc. | Jul 1, 2021 | 1 | -$2.73M | 4 | Jul 1, 2021 | Chief Operating Officer |